US Patent Issued to HepC Terapia Kereskedelmi es Szolgaltato Zrt. on Nov. 3 for "Use of a birnavirus for the treatment of a disease caused by varicella zoster virus (VZV)" (Hungarian Inventor)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,028, issued on Nov. 3, was assigned to HepC Terapia Kereskedelmi es Szolgaltato Zrt. (Budapest, Hungary).

"Use of a birnavirus for the treatment of a disease caused by varicella zoster virus (VZV)" was invented by Tibor Bakacs (Budapest, Hungary).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions relating to a Birnavirus for use in the treatment of a disease caused by a Varicella zoster virus (VZV). Further, the present disclosure provides compositions and methods comprising a Birnavirus and at least one further active agent for use in the treatment of a disease caused by VSV."

The patent was filed on Nov. 18,...